<DOC>
	<DOCNO>NCT02061033</DOCNO>
	<brief_summary>Patients hemophilia level deficient factor ( ) may express different severity clinical presentation bleeding tendency . Therefore test could determine overall hemostasis rather simple concentration single deficient factor may correlate good clinical phenotype patient . The investigator therefore study usefulness global hemostatic method ( endogenous thrombin potential ( ETP ) , overall hemostatic potential ( OHP ) , fibrin clot structure ) microparticles prediction severity bleed estimation response treatment patient hemophilia . Since hemophilia patient prophylactic treatment virtually bleed , additional patient treated demand include enable study possible modulatory effect different hemostatic factor ( particularly prothrombotic thrombin activatable fibrinolysis inhibitor ( TAFI ) ) clinical presentation . The investigator correlate factor clinical severity global hemostatic method . The investigator expect prove individual tailoring treatment , may enable lower prophylactic dose factor concentrate without increase risk bleeding , justified hemophilia patient . This approach would reduce amount necessary factor concentrate certain patient decrease cost ( represent extensive burden health care system ) treatment without potential risk patient .</brief_summary>
	<brief_title>Global Hemostatic Methods Hemophilia Von Willebrand 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Hemophilia A</mesh_term>
	<mesh_term>Hemophilia B</mesh_term>
	<mesh_term>Von Willebrand Diseases</mesh_term>
	<mesh_term>Hemostatics</mesh_term>
	<criteria>patient bleed disorder</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Hemophilia A</keyword>
	<keyword>Hemophilia B</keyword>
	<keyword>Von Willebrand 's Disease</keyword>
	<keyword>Endogen thrombin potential</keyword>
	<keyword>Overall hemostatic potential</keyword>
	<keyword>Microparticles</keyword>
	<keyword>Fibrin clot</keyword>
</DOC>